$55.00
Manufacturer: France
The drug is prescribed by a gynecologist in the following clinical cases: in case of dysbacteriosis of the vaginal mucosa of a woman caused by various factors (including the consequences of pre-treatment of bacterial vaginosis using antibiotics) – in order to normalize the local balance of the microflora; for prophylactic purposes of vaginal dysbiosis at the preparatory stage of planned gynecological operations; for prophylactic purposes of vaginal dysbiosis at the prenatal preparatory stage of planned gynecological operations; when preparing for delivery of women who are at risk for bacterial vaginosis during pregnancy, in order to minimize infection of the newborn during childbirth.
Description
Laktojinal Composition
Magnesium stearate – 3.41 mg;
lactose monohydrate – 5.59 mg;
potato starch (~ 41% of the mass of the lyophilisate);
lactose monohydrate (~ 20.6% by weight of the lyophilisate);
sodium glutamate (~ 4.5% by weight of the lyophilisate);
sodium thiosulfate (~ 26.8% by weight of the lyophilisate);
gelatin.
Laktojinal Description
Vaginal capsules are transparent, gelatinous. The content of the capsules is a powder of light yellow with a brownish shade.
Lactobacillus casei is a gram-positive rod-shaped anaerobic non-spore-forming bacteria. Lactobacillus casei is the normal obligate flora of the oral cavity, intestines, vulva and vagina of humans. Lactobacillus casei, along with other types of lactobacilli (including Lactobacillus acidophilus, Lactobacillus fermentum, Lactobacillus cellobiosum), are represented in the normal flora of the vulva and vagina of a woman.
Colonization of the vagina with live bacilli Lactobacillus casei rhamnosus Doderleini creates a physiological environment in the vagina. The Lactobacillus casei rhamnosus Doderleini strain in the Lactozhinal preparation has antagonistic activity against a wide range of pathogenic and opportunistic bacteria (including Staphylococcus spp., Proteus spp., Enteropathogenic Escherichia coli), improves local metabolic processes and helps restore natural local immunity.
With the introduction of the capsule of the drug Lactozhinal into the vagina, the gelatinous shell of the capsule dissolves with the release of a lyophilized culture of live lactobacilli.
It has been shown in vitro that Lactobacillus casei rhamnosus Doderleini, within a few hours after administration, leads to the necessary decrease in pH, contributing to the restoration of the natural microflora of the vagina.
Lactobacillus deficiency is one of the important factors in the development of vulvovaginal candidiasis. Lactobacilli are physiological antagonists of yeast-like fungi of the genus Candida due to the secretion of antifungal substances and competition for receptors on vaginal epithelial cells (inhibit the attachment of Candida fungi to vaginal epithelial cells, inhibit their growth and reproduction).
The results of a clinical study showed the effectiveness of the drug Laktozhinal in restoring the normal microflora of the vagina and in the prevention of recurrent vulvovaginal candidiasis when used after completion of therapy with antifungal drugs.
Laktojinal Indications
Lactozhinal LP tablets can be used:
after taking antibacterial drugs;
repeated courses of antifungal infection.
Contraindications
Vulvovaginal candidiasis (thrush).
Age up to 18 years (efficacy and safety have not been established).
Hypersensitivity to the components of the drug.
Application features
After insertion, the capsule dissolves without leaving stains or odors on the laundry. The drug is intended for use in women over 18 years of age.
Method of administration and dosage
For easier insertion, moisten the tablet with a little water. Insert deep into the vagina before going to bed.
1 tablet every 4 days:
to restore the microflora of the vagina: 2 tablets;
to prevent relapse: 6 tablets.
Adverse Reactions
Itching, burning, redness in the genital area, increased mucous discharge from the vagina.
Recent Reviews